Page 84 - Sohini Das

Biological E ties up with Canadian firm Providence for mRNA Covid vaccine

The vaccine, named PTX-COVID19-B, is under development in Canada; the deal assumes significance as this gives India access to the mRNA tech

Major states may finish Covid-19 vaccination by July 2022: Report

At the current pace, UP and Maharashtra would take 15 and 17 months respectively to cover their universal population

Wockhardt plans tie-ups for next-gen Covid-19 vax, aims to make 2 bn doses

Company aims to make 2 billion doses of vaccines in 1 to 2 years

For a Covid-19 vaccine, journey from lab to jab can take up to 4 months

Manufacturing alone takes 40-120 days

We have sole selling rights, beware of fake agents of Sputnik-V: Dr Reddy's

Hyderabad-based pharma major says it isn't supplying Russia jab to residential societies

GSK says it aims to bring FDA-approved antibody therapy to India for Covid

Treatment with Sotrovimab resulted in an 85 per cent reduction in the risk of hospitalization, says company.

Decoded: Why are black, white and yellow fungal infections on the rise now?

What are these infections, why are their cases rising and how does one protect against them?

Sun Pharma Q4 net more than doubles to Rs 894 cr on better operational show

Low base supported overall performance; consolidated sales from operations came in at Rs 8,431 crore, up 4.4% YoY

India starts preparation to make Covid-19 care safe for children

Treatment protocols, wards with space for parents, and specially trained staff are some measures

Cipla launches Roche's Covid antibody cocktail in India for Rs 60k per dose

The antibody cocktail (Casirivimab and Imdevimab) is to be administered for the treatment of mild to moderate Covid-19 in adults and pediatric patients

2-DG drug for Covid-19 treatment: Here're the benefits and concerns

The idea behind using 2-DG in Covid-19 is that along with other anti-virals, it can help prevent replication of the Sars-CoV-2 virus in inflamed lung cells of Covid-19 patients

Bharat Biotech may receive Covaxin drug substance from IIL in June

The Union health ministry said recently that it expects 750 million doses of Covishield to be available between August and December.

Chemists threaten to join lockdown, seek Covid-19 vaccination on priority

The medical devices makers' industry body, too, has written to the NITI Aayog seeking vaccination on priority.

Self-use Covid-19 testing kits to be available at stores for Rs 250

Mylab's kit gets ICMR nod; labs say this won't impact demand for RT-PCR tests

SII, Bharat Biotech to get bulk of Rs 15K-crore profit pool: Report

At present, SII sells its vaccine Covishield to the Centre for Rs 150 per dose, to state governments for Rs 300 and to private hospitals for Rs 600.

Covid-19 crisis: Over no response, states relax global vaccine tender norms

BMC was the first civic body in the country to float a global tender for purchasing vaccines

Biotech cos Tzar Labs and Epigeneres to launch early-detection cancer tests

Firms claim breakthrough with their RNA-marker tech which detects cancer even in stage zero

May start vaccine exports by year end, India remains priority: Serum

Company says it never exported vaccines at the cost of the people of India

Covid-19 crisis: Pharma majors step up support to affected employees

A company spokesperson said this benefit will be over and above the existing group term insurance

Covaxin capacity scaled up to 500 million doses a year: Bharat Biotech

Vaccine effective against all emerging coronavirus variants, says study